AntriaBio closes on $13M private investment, plans to dose first patient in July

AntriaBio closes on $13M private investment, plans to dose first patient in July

LOUISVILLE -- AntriaBio, Inc. ( (OTCQB: ANTB) , a clinical stage biopharmaceutical company specializing in the development of innovative drug therapies to improve the lives of patients with... Read More

Tuesday July 18, 2017 0 comments Tags: Louisville, AntriaBio, AB101

AntriaBio names Hoyoung Huh as chair of company's scientific advisory board

AntriaBio names Hoyoung Huh as chair of company's scientific advisory board

LOUISVILLE - AntriaBio Inc. (OTCQB: ANTB), a biopharmaceutical corporation focused on developing novel extended release therapies, announced Dr. Hoyoung Huh , one of the company's... Read More

By: InnovatioNews Monday January 12, 2015 0 comments Tags: AB101, AntriaBio, diabetes, Hoyoung Huh, Louisville, Nevan Elam

AntriaBio raises $7M in private placement transaction, collects $18M in total 2014 investment

AntriaBio raises $7M in private placement transaction, collects $18M in total 2014 investment

LOUISVILLE - AntriaBio Inc. (OTCQB: ANTB), a biopharaceutical corporation focused on developing novel extended release therapies, announced it recently raised approximately $7 million in a... Read More

By: InnovatioNews Friday January 9, 2015 0 comments Tags: AB101, AntriaBio, diabetes, Louisville, Nevan Elam

AntriaBio announces successful tests for AB101 once-weekly basal insulin diabetes treatment

AntriaBio announces successful tests for AB101 once-weekly basal insulin diabetes treatment

LOUISVILLE - AntriaBio Inc. (OTCQB: ANTB), a biopharmaceutical corporation focused on developing novel extended-release therapies, announced it has successfully completed a series of in-vitro... Read More

By: InnovatioNews Thursday January 8, 2015 0 comments Tags: AB101, AntriaBio, Brian Roberts, C. Ronald Kahn, diabetes, Louisville

Silicon Valley-based AntriaBio establishes Louisville manufacturing and research facility

Silicon Valley-based AntriaBio establishes Louisville manufacturing and research facility

LOUISVILLE - Silicon Valley-based AntriaBio Inc. (OTCQB: ANTBD), a biopharmaceutical company focused on developing therapeutics for the treatment of diabetes and metabolic disease, announced it... Read More

By: InnovatioNews Tuesday May 13, 2014 0 comments Tags: AB101, AntriaBio, Louisville, Nevan Elam, Silicon Valley